Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

Prescribed List (Jersey): Changes as of 1 September 2020

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

  • demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision

  • providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made on 18 August 2020

Decision Reference:  MD-S-2020-0051

Decision Summary Title :

DS Prescribed list as of 1 September 2020

Date of Decision Summary:

29 July 2020

Decision Summary Author:

Policy Principal

Decision Summary:

Public or Exempt?

Public

Type of Report:

Oral or Written?

Written

Person Giving

Oral Report:

NA

Written Report

Title :

WR report PBAC 14 July 2020

Date of Written Report:

29 July 2020

Written Report Author:

Prescribing Advisor

Written Report :

Public or Exempt?

 

Public

Subject: Changes to be made to the Prescribed List (Jersey) as of 1 September 2020

Decision(s): Further to Article 15, paragraphs (11) and (12), of the Health Insurance (Jersey) Law 1967, and having consulted with the Pharmaceutical Benefit Advisory Committee, the Minister decided to make amendments to the Prescribed List with effect from 1 September 2020 as set out in the accompanying report and supporting document.

Reason(s) for Decision: The Pharmaceutical Benefit Advisory Committee met to consider applications for changes to the Prescribed List and made the following recommendations-

1.      Items to be added to the Prescribed List

 

1.1 Vortioxetine 5mg, 10mg, 15mg tablet

1.2 Esomeprazole 20mg, 40mg gastro-resistant capsule

1.3 Estradiol 1.53mg/dose transdermal spray (Lenzetto)

1.4 Synalar N ointment

1.5 Medroxyprogesterone 100mg tablet

1.6 Isosorbide mononitrate 60mg m/r tablet

1.7 Methotrexate 22.5mg and 30mg solution for injection pre-filled device

1.8  Budesonide 9mg m/r tablet

 

  1. Items to be removed from the Prescribed List

 

2.1  Furosemide 5mg/5ml oral solution

2.2  Ketoprofen 50mg capsules

2.3  Spironolactone 10mg/5mL oral suspension

 

  1. Other changes to the Prescribed List

 

3.1   The requirement for prescriptions for acamprosate and nalmefene to be validated by the Alcohol & Drugs Service before dispensing is suspended during the COVID-19 pandemic pending review of the process.

 

The above recommendations reflect current evidence and expert advice and ensure that patients in Jersey have access to an appropriate range of modern, safe and effective treatments from their GPs and community prescribers at a proportionate cost to the Fund.

 

Resource Implications: The overall financial impact of the above changes is expected to be a small cost pressure of up to £10,000 per annum.  

 

Action required: Health Zone Manager at Customer and Local Services to issue a public notice listing amendments and notify all approved medical practitioners and approved contractors.

Signature:

 

 

Position:

Minister for Social Security

 

Date Signed:

 

 

Date of Decision (If different from Date Signed):

 

Back to top
rating button